Back to results
US 2001/0041699 A1Published application
Method for treating osteoporosis in castrated prostatic cancer patients
AssigneeBarr Laboratories, Inc.
InventorROBERT G. BELL
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for preventing or treating osteoporosis in a castrated prostatic cancer patient, by administering to the patient an amount of from 10 mg to 300 mg cyproterone acetate per day. The present therapy is compatible with the patients' anticancer treatment.
Claims18
A method for preventing or treating osteoporosis in a castrated prostatic cancer patient, comprising administering to said patient an amount of from 10 mg to 300 mg cyproterone acetate per day.
Dependencies are inferred from the claim text.